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This is a weekly summary of the daily COVID-19 health evidence summary (HES) which are based 
on 3 hours of desk-based research each day. The summary is not intended to be a comprehensive 
summary of available evidence on COVID-19 but aims to make original documents easily 
accessible to decision makers which, if relevant to them, they should go to before making 
decisions. 
Clinical characteristics and management 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
25.06.2020 Neurological 
and 
neuropsychiatric 
complications of 
COVID-19 in 
153 patients: a 
UK-wide 
surveillance 
study 
The Lancet 
Psychiatry |  
Article 
 First known 
nationwide, 
cross-speciality 
surveillance 
study of acute 
neurological and 
psychiatric 
complications of 
COVID-19 
 Altered mental 
status was the 
second most 
common 
presentation, 
comprising 
encephalopathy 
or encephalitis 
and primary 
psychiatric 
diagnoses, often 
occurring in 
younger 
patients 
 Valuable and 
timely data for 
clinicians, 
researchers and 
funders to 
Neurological, 
neuropsychiatric 
2 
inform 
immediate next 
steps in C19 
neuroscience 
research and 
health policy 
25.06.2020 COVID-19 in 
children and 
adolescents in 
Europe: a 
multinational, 
multicentre 
cohort study  
The Lancet 
Child & 
Adolescent 
Health 
 Included as data 
on paediatric 
C19 remains 
few and mostly 
from China 
 C19 is a 
generally mild 
disease in 
children, 
including infants 
 A small 
proportion 
though do 
develop severe 
disease 
requiring ICU 
admission and 
prolonged 
ventilation, 
although fatality 
is rare 
 Data reflects 
current 
uncertainties 
over treatment 
options 
children 
23.06.2020 The prevalence 
of symptoms in 
24,410 adults 
infected by the 
novel 
coronavirus 
(SARS-CoV-2; 
COVID-19): a 
systematic 
review and 
meta-analysis of 
148 studies 
from 9 countries 
PLoS ONE | 
Article 
 Study confirms 
‘classic’ 
symptoms of 
adults infected 
with SARS-
CoV-2 – a 
persistent cough 
and fever as the 
most prevalent 
symptoms 
associated with 
C19 with other 
major symptoms 
including 
fatigue, losing 
the ability to 
small and 
difficulty in 
breathing 
 This study 
ratifies the list of 
symptoms listed 
by the WHO at 
symptoms 
3 
the start of the 
pandemic 
 However, there 
is a large 
proportion of 
infected adults 
which 
symptoms alone 
do not identify 
22.06.2020 Are men who 
smoke at higher 
risk for a more 
severe case of 
COVID-19 than 
women who 
smoke? A 
Systematic 
Review 
medRxiv (non-
peer reviewed) | 
Article 
 Six cohorts from 
China were 
analysed and a 
crude odds ratio 
was manually 
calculated. 
 Results: 
Patients with a 
smoking history 
were 
approximately 2 
times (95% CI= 
1.036-1.883) as 
likely to suffer 
from severe 
clinical 
manifestations 
of COVID-19 
compared to 
patients without 
a smoking 
history.  
smoking 
22.06.2020 Management of 
patients with 
liver 
derangement 
during the 
COVID-19 
pandemic: an 
Asia-Pacific 
position 
statement 
Lancet 
gastroenterology 
and hepatology | 
Review 
 It is common to 
encounter 
patients with 
COVID-19 with 
abnormal liver 
function, either 
in the form of 
hepatitis, 
cholestasis, or 
both. 
 Clinical 
scenarios 
covering the use 
of 
pharmacological 
treatment for 
COVID-19 in the 
case of liver 
derangement, 
and assessment 
and 
management of 
patients with 
chronic hepatitis 
Liver, Asia-
Pacific 
4 
B or hepatitis C, 
non-alcoholic 
fatty liver 
disease, liver 
cirrhosis, and 
liver 
transplantation 
during the 
pandemic are 
discussed. 
Epidemiology and modelling  
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
21.06.2020 Modelling 
the 
pandemic: 
attuning 
models to 
their context 
BMJ Global 
Health | 
Analysis 
 Mathematical models 
produce evidence to 
inform policy decisions 
but sociological and 
anthropological work 
shows how these models 
do not always fit with 
local implementation 
 This study draws on 
cases of Ebola and 
influenza to map how 
sociological and 
anthropological research 
contributes in the 
modelling of pandemics 
to consider lessons for 
C19 
Modelling, 
sociology, 
anthropology, 
context 
23.06.2020 SARS CoV-
2 
serosurvey 
in Addis 
Ababa, 
Ethiopia 
medRxiv 
(non-peer 
reviewed) | 
pre-print 
 3 out of 99 asymptomatic 
people recruited from a 
clinical laboratory in the 
general population in 
May, 2020 in Addis 
Ababa tested positive for 
SARS-CoV-2 IgG 
 Plausible population 
prevalence values range 
from 1.0 to 8% when 
taking into account pre-
test probability and the 
sampling scheme 
 Results suggest that the 
large majority of the 
general population in 
Addis Ababa are 
currently susceptible to 
COVID-19 
  
5 
22.06.2020 Estimation 
of fatality 
rate in 
Africa 
through the 
behavior of 
COVID-19 
in Italy 
relevance to 
age profiles 
medRxiv 
(non-peer 
reviewed) | 
Article 
 We compared the CFR 
observed in Italy with the 
age profiles in 46 Africa 
countries and 2 territories 
which are already 
confirmed COVID-19 
case.  
 The estimation of the 
CFR in Africa ranges 
between (1.0%-5.4%) 
while in Italy is 10.1%. 
The five highest CFR 
countries and territories 
in Africa are Reunion 
(5.4%), Mauritius (5.1 %), 
Tunisia (3.9%), 
Seychelles (3.8%) and 
Morocco (3.3%). The last 
three countries with low 
CFR are Uganda (1.0%), 
Zambia (1.1%) and 
Angola (1.1%). The 
observed difference is 
related to the age 
profiles. 
Africa, age 
20.06.2020 The 
Relationship 
between the 
Global 
Burden of 
Influenza 
from 2017-
2019 and 
COVID-19 
medRxiv 
(non-peer 
reviewed) | 
Article 
 Europe and Central Asia 
and North America 
ranked first and second 
for COVID-19 and 
second and first for 
influenza, respectively. 
East Asia and the Pacific 
traditionally ranked 
higher for influenza but to 
date, has been less 
affected by COVID-19. 
Between regions, Sub-
Saharan Africa ranked 
amongst the least 
affected by both influenza 
and COVID-19. 
 
  
6 
Infection Prevention and Control 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
  
22.06.2020 Assessment 
of 
Coronavirus 
Disease 
2019 
Community 
Containment 
Strategies in 
Shenzhen, 
China 
Jama 
 This retrospective case 
series included 7 
imported COVID-19 
cases and 800 
individuals at high risk. 
After the implementation 
of community measures, 
no locally acquired case 
of COVID-19 with 
indirect links to 
confirmed cases was 
identified in the 
community. 
 The findings of this 
study suggest that the 
implementation of 
community containment 
strategies by a 
multidisciplinary team 
may limit the community 
transmission of COVID-
19. 
Community 
containment,  
  
18.06.2020 Use of N95, 
Surgical, and 
Cloth Masks 
to Prevent 
COVID-19 in 
Health Care 
and 
Community 
Settings: 
Living 
Practice 
Points From 
the American 
College of 
Physicians 
Annals of 
Internal 
Medicine 
 In this article, the 
American College of 
Physicians (ACP) 
provides 
recommendations 
based on the best 
available evidence 
through 14 April 2020 
on the effectiveness of 
N95 respirators, surgical 
masks, and cloth masks 
in reducing transmission 
of infection. 
  
Face masks,  
 
21.06.2020 Risk of 
SARS-CoV-2 
infection from 
contaminated 
medRxiv 
(non-peer 
reviewed) | 
Article 
 Authors quantify SARS-
CoV-2 virus survivability 
within water and the risk 
of infection posed by 
faecal contaminated 
water within 39 
countries.  
Infection 
 
7 
water 
systems 
 They identify that the 
virus can remain stable 
within water for up to 25 
days, and country 
specific relative risk of 
infection posed by 
faecal contaminated 
water is related to the 
environment. Faecal 
contaminated rivers, 
waterways and water 
systems within countries 
with high infection rates 
can provide infectious 
doses >100 copies 
within 100 ml of water. 
The implications for 
freshwater systems, the 
coastal marine 
environment and virus 
resurgence are 
discussed. 
Testing 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
25.06.2020 Antibody 
tests for 
identification 
of current 
and past 
infection 
with SARS-
CoV-2 
Cochrane SR 
- Diagnostic 
 The sensitivity of antibody 
tests is too low in the first week 
since symptom onset to have a 
primary role for the diagnosis 
of C19 
 But may still have a role with 
other testing in individuals 
presenting later when RT-PCR 
tests are negative or not done 
 Antibody tests are likely to be 
useful for detecting previous 
SARS-CoV-2 infection if used 
15 or more days after onset of 
symptoms 
 However, duration of antibody 
rises remains unknown, with 
little data beyond 35 days post-
symptom onset  
 Authors are therefore uncertain 
about the utility of these tests 
for seroprevalence surveys for 
reasons of public health 
management 
Antibody 
tests 
8 
 It is likely that the accuracy of 
tests when used in clinical care 
will be lower than reported in 
the included studies 
 It remains unclear whether 
tests are able to detect lower 
antibody levels likely seen with 
milder and asymptomatic C19 
disease given sensitivity has 
mainly been evaluated in 
hospitalised patients 
 Authors highlight that the 
design, execution and 
reporting of studies of the 
accuracy of C19 tests requires 
‘considerable improvement’ 
 Studies must report data on 
sensitivity disaggregated by 
time since onset of symptoms, 
C19 RT-PCR-positive and 
negative cases within WHO 
case definitions 
 All results of test evaluations 
must be made available in the 
public domain to prevent 
selective reporting 
22.06.2020 Genetic 
diversity 
among 
SARS-CoV2 
strains in 
South 
America 
may impact 
performance 
of Molecular 
detection 
medRxiv 
(non-peer 
reviewed) | 
Article 
 Results suggest that E-gene 
stands as the most conserved 
and reliable target when 
considering single-gene target 
testing for molecular diagnosis 
of SARS-CoV-2 in South 
America. 
South 
America, 
testing 
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Therapeutics 
Publication 
date 
Title/URL Journal/Article 
type 
Summary             Keywords 
24.06.2020 Tocilizumab in 
patients with 
severe COVID-
19: a 
retrospective 
cohort study 
The Lancet 
Rheumatology 
| Article 
 This multi-centre, 
retrospective, 
observational cohort 
study of 544 adults 
with severe C19 
pneumonia in Italy, 
found that treatment 
with tocilizumab, 
whether 
administered 
intravenously or 
subcutaneously, 
might reduce the 
risk of invasive 
mechanical 
ventilation or death 
in patients with 
severe C19 
pneumonia  
 Severe C19, 
tocilizumab 
23.06.2020 Effect of 
dexamethasone 
in hospitalized 
patients with 
COVID-19: 
preliminary 
report 
medRxiv (non-
peer 
reviewed) | 
pre-print 
 RECOVERY 
preliminary results 
for the comparison 
of dexamethasone 
6mg given once 
daily for up to ten 
days vs usual care 
alone 
 Dexamethasone 
reduced 28-day 
mortality in 
hospitalised 
patients with C19 
receiving invasive 
mechanical 
ventilation or 
oxygen at 
randomisation, but 
not among patients 
not receiving 
respiratory support 
 Trial was conducted 
in the UK but 
important to enable 
access of severe 
cases in LICs to 
dexamethasone as 
a treatment option 
 dexamethasone 
10 
Vaccines 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
20.06.2020 Evaluation of 
the 
immunogenicity 
of prime-boost 
vaccination with 
the replication-
deficient viral 
vectored 
COVID-19 
vaccine 
candidate 
ChAdOx1 
nCoV-19 
bioRxiv (non-
peer 
reviewed) | 
pre-print 
 A single dose of 
ChAdOx1 nCoV-19 
induced antigen-
specific antibody and T 
cell responses in mice 
and pigs 
 A booster immunisation 
enhanced antibody 
responses, especially in 
pigs, with a significant 
increase in SARS-CoV-
2 neutralising titres 
 These results suggest 
that it may be possible 
to boost efficacy of the 
Oxford vaccine with a 
second follow-up 
vaccination  
ChAdOx1 
nCoV-19, 
prime-
boost, 
pigs 
Indirect impact of COVID-19 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
25.06.2020 Attendance to 
HIV 
antiretroviral 
collection 
clinic 
appointments 
during 
COVID-19 
lockdown. A 
single center 
study in 
Kigali, 
Rwanda 
Aids and 
Behaviour | 
Notes from 
the field 
 Cross-sectional 
study at the 
University Teaching 
Hospital of Kigali, 
ART clinic 
 Note limitations of 
generalisability of 
findings from a 
single-center study 
and factors 
reported do not 
show causality. 
Findings do though 
warrant further 
formative research 
HIV care, 
Rwanda 
24.06.2020 Mitigating the 
impact of 
COVID-19 on 
countries 
Global Fund | 
Report 
 Analyses from 
WHO, UNAIDS and 
the Stop TB 
Partnership and 
others suggest the 
TB, HIV, 
malaria 
11 
affected by 
HIV, 
tuberculosis 
and malaria 
annual death toll 
across HIV, TB and 
malaria could 
nearly double, 
wiping out years of 
progress 
 This report 
estimates that 
countries affected 
by HIV, TB and 
malaria urgently 
needs US$28.5 
billion to protect 
progress made in 
the fight against 
these diseases 
 24.06.2020 Voices from 
the frontline: 
findings from 
a thematic 
analysis of a 
rapid online 
global survey 
of maternal 
and newborn 
health 
professionals 
facing the 
COVID-19 
pandemic 
 BMJ Global 
Health | 
Article 
 Analysis from 714 
maternal and 
newborn health 
professionals 
 Findings show a 
substantial 
knowledge gaps 
exist in guidance in 
management of 
maternity cases 
with or without 
COVID-19 
 Levels of stress 
increased among 
health 
professionals 
globally due to a 
change in working 
hours, difficulties in 
getting to work and 
staff shortages 
 Health 
professionals are 
worried about the 
impact on health 
outcomes e.g. 
reduced access to 
antenatal care, 
shorter length of 
stay in facilities 
after birth 
Health 
professionals, 
maternal and 
newborn 
health 
12 
 Authors 
recommend that 
formal information-
sharing channels 
for providers be 
established and 
mental health 
support provided 
 This study highlights 
the susceptibility of 
maternity care 
services to 
emergencies, 
including reversal of 
hard-won gains 
19.06.2020 COVID-19 
Pandemic 
and Mitigation 
Strategies: 
Implications 
for Maternal 
and Child 
Health and 
Nutrition 
The American 
Journal of 
Clinical 
Nutrition 
 This review highlights 
key areas of concern 
for maternal and child 
nutrition during and in 
the aftermath of 
COVID-19 while 
providing strategic 
guidance for countries 
in their efforts to 
reduce maternal and 
child undernutrition. 
Nutrition 
Social Science 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
24.06.2020 Knowledge, 
attitude, 
perceptions 
and 
practice 
towards 
COVID-19: 
a 
systematic 
review and 
meta-
analysis 
medRxiv 
(non-peer 
reviewed) | 
pre-print 
 This study summarises the 
level of risk reduction 
practices about C19 through 
systematic review 
 Lack of C19-relted 
knowledge, positive 
perceptions, and preventive 
practices was detected and 
seems widespread 
 Evidence-based practices on 
risk communication and 
raising awareness should be 
planned by local governments 
in collaboration with 
healthcare organisations 
 Educational initiatives for 
HCWs to wear a face mask 
and practicing hand hygiene 
should be prioritised 
Knowledge, 
attitude, 
perception 
13 
June 2020 Knowledge, 
attitudes 
and 
practices of 
COVID-19 
among 
income-
poor 
households 
in the 
Philippines: 
A cross-
sectional 
study 
Journal of 
Global Health 
 Objective of this study was to 
gain an understanding of how 
COVID-19 was perceived by 
households experiencing 
extreme poverty in the 
Philippines. 
 Conclusion: There is a need 
for targeted health education 
as a response strategy to 
COVID-19 in low-income 
settings, and it is important 
that strategies are 
contextually relevant. 
Understanding KAPs among 
populations experiencing 
extreme poverty will be 
important as tailored guidance 
for public health response and 
communication strategies are 
developed for LMICs 
 
  
14 
Leadership and governance 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
17.06.2020 The COVID-
19 
Pandemic 
and the 
Pathology of 
the 
Economic 
and Political 
Architecture 
in Cameroon 
Health care | 
article 
 Examines the factors 
restricting an effective 
response to the COVID-
19 pandemic in 
Cameroon. Article argues 
that structural adjustment 
policies in the 1980s and 
1990s as well as 
corruption and limited 
investment in recent times 
have severely weakened 
the country's health 
system.  
 This article also 
emphasises the 
interconnection between 
poverty, slums, and 
COVID-19. This 
interconnection brings to 
the fore inequality in 
Cameroon. Arguably, this 
inequality could facilitate 
the spread of COVID-19 
in the country.  
 This article draws 
attention to the political 
forces shaping the 
response to the pandemic 
and contends that in 
some regions in the 
country, the lack of an 
effective response to the 
pandemic may not 
necessarily be due to a 
lack of resources.  
 At times, medical supplies 
and other forms of 
assistance may be 
available, but structural 
violence impairs access 
to these resources. 
Politics must be brought 
into the COVID-19 
discourse, as it shapes 
the response to the 
pandemic. 
Inequality, 
governance 
15 
19.06.2020 COVID -19 
and the 
State of 
African 
Neurology 
European 
journal of 
neurology 
 Expectations of Africa 
having high rates of 
infection and death from 
COVID-19 have, as yet, 
not materialised. At the 
time of writing, all 54 
countries have officially 
reported COVID-19 
cases; 123,724 people 
have tested positive for 
the disease and 3,668 
people have died.  
 The reasons for such low 
levels may be due, in 
part, to countries rapid 
responses 
  
Health systems 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
 23.06.2020 Cost-
effectiveness 
and return on 
investment of 
protecting 
health 
workers in 
low- and 
middle-
income 
countries 
during the 
COVID-19 
pandemic 
 medRxiv 
(non-peer 
reviewed) | 
pre-print 
 LMICs, regional and 
national estimates of 
mortality for HCWs, 
cost-effectiveness and 
return on investment 
are presented  
 Wide-scale 
procurement and 
distribution of PPE for 
LMICs is essential to 
prevent widespread 
HCW morbidity and 
mortality. It is cost-
effective and yields a 
large downstream 
return on investment  
HCW, cost-
effectiveness, 
ROI 
18.06.2020 An Adaptive 
Model of 
Health 
System 
Organization 
and 
Responses 
Helped 
Vietnam to 
Successfully 
Halt the 
The 
international 
journal of 
health 
planning and 
management | 
Perspective 
 This commentary 
shares with the 
international 
community how an 
adaptive model of 
health system 
organization and 
responses helped 
Vietnam to break 
transmission of 
coronavirus. 
 An effective model is 
adaptive to time and 
Health 
systems 
16 
Covid-19 
Pandemic: 
What 
Lessons Can 
Be Learned 
From a 
Resource-
Constrained 
Country 
context, and mobilizes 
and engages the wider 
society. - Merging of 
different health system 
units into Center for 
Diseases Controls was 
a health system 
organization that 
saved massive 
resources.  
- Early establishment 
of a formal committee 
responding to the 
pandemic helped unify 
every public health 
strategy.  
- Mobilization of 
different stakeholders 
and communities 
added resources and 
facilitated a 
synchronous 
implementation of 
response strategies, 
even where those 
strategies involved 
significant personal or 
financial sacrifice.  
- National training on 
Covid‐19 treatment for 
healthcare 
professionals across 
the entire hospital 
system was useful to 
expand the health 
service availability.  
- Quickly published 
response guidelines 
helped to activate 
every level of the 
health system and 
involve every sector of 
society. A strategy of 
keeping high alert and 
preemptive action is 
also essential for 
coping with the 
pandemic. 
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Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article 
type 
Author(s) 
27.06.2020 Generation coronavirus? The Lancet | 
Editorial 
  
27.06.2020 Access to health care under 
threat in Afghanistan 
The Lancet | 
World Report 
Sharmila Devi 
27.06.2020 Offline: The second wave The Lancet | 
Comment 
Richard Horton 
26.06.2020 Act-Accelerator update WHO | News   
25.06.2020 Rohingya refugees at high risk 
of COVID-19 in Bangladesh 
The Lancet 
Global Health | 
Comment 
Mohammad Mainul Islam 
MD Yeasir Yunus 
25.06.2020 Are we ready to mitigate the 
impacts of COVID-19 on family 
planning and contraceptives? 
GFF | Blog Brendan Hayes 
Michelle Weinberger 
Julia White 
John Skibiak 
25.06.2020 The state of health care quality 
measurement in the era of 
COVID-19 
JAMA | Viewpoint J. Matthew Austin 
Allen Kachalia 
  
25.06.2020 Emerging lessons from 
community-led COVID-19 
responses in urban areas 
IIED    
July 2020 Stigma during the COVID-19 
pandemic 
The Lancet 
Infectious 
Diseases | 
Newsdesk 
Sanjeet Bagcchi 
18 
July 2020 COVID-19 in Iran: round 2 The Lancet 
Infectious 
Diseases | 
Newsdesk 
Priya Venkatesan 
24.06.2020 Exclusive: Women, babies at 
risk as COVID-19 disrupts 
health services, World Bank 
warns 
Reuters | News Kate Kelland 
24.06.2020 Why covid-19 antibody tests are 
not the game changer the UK 
government claims 
BMJ | Feature   
15.06.2020 Power and politics: the case for 
linking resilience to health 
system governance 
BMJ Global 
Health | Editorial 
Stephanie M Topp 
July 2020 Africa’s COVID-19 health 
technologies’ watershed 
moment 
The Lancet 
Digital Health | 
News 
Paul Adepoju 
24.06.2020 Globalisation in the time of 
COVID-19: repositioning Africa 
to meet the immediate and 
remote challenges 
Globalization and 
Health | 
Commentary 
Sanni Yaya et al 
24.06.2020 Commercial influence and 
covid-19 
BMJ | Editorial   
24.06.2020 From Ebola to COVID-19: How 
Uganda can adapt its response 
to the current crisis 
Health Policy and 
Planning 
Debated | Blog 
Federica Margini 
Anooj Pattnaik 
Angellah Nakyanzi 
23.06.2020 Beyond COVID-19 
(coronavirus): What will be the 
new normal for health systems 
and universal health coverage? 
World Bank | 
Blog 
Agnes Soucat 
Francesca Colombo 
Feng Zhao 
23.06.2020 Besides population age 
structure, health and other 
PNAS | Letter Marilia R. Nepomyceno et 
al. 
19 
demographic factors can 
contribute to understanding the 
COVID-19 burden 
23.06.2020 In poor countries, many Covid-
19 patients are desperate for 
oxygen 
NY Times | 
Global Health 
News 
Donald G. McNeil 
23.06.2020 The colliding epidemics of 
COVID-19, Ebola, and measles 
in the Democratic Republic of 
the Congo 
The Lancet 
Global Health | 
Comment 
Jean B Nachega et al 
23.06.2020 COVID-19 scientific and public 
health policy update (23 June 
2020) 
Africa CDC   
22.06.2020 COVID-19 & violence against 
women and children: what have 
we learned to far? 
CGD | Notes Amber Peterman 
Megan O’Donnell 
Tia Palermo 
22.06.2020 Children with COVID-19 at a 
specialist centre: initial 
experience and outcome 
Lancet Child & 
Adolescent 
Health | 
Correspondence  
Richard W Issitt, John 
Booth 
et al. 
22.06.2020 Mini organs reveal how the 
coronavirus ravages the body 
Nature | news   
18.06.2020 Africa: In The Fight Against 
 COVID-19, Africa is The 
Unsung Continent 
All Africa   
19.06.2020 Coronavirus Disease 2019 
(COVID ‐19): Potential 
implications for weak health 
systems and conflict zones in 
the Middle East and North Africa 
region 
The international 
journal of health 
planning and 
management | 
short 
communication 
Omar B. Da'ar, Mohamed 
Haji,  Hoda Jradi 
20 
18.06.2020 Is the effect of COVID‐19 on 
children underestimated in low‐ 
and middle‐ income countries? 
Acta Paediatrica  Justus Simba, Ian Sinha, 
Patrick Mburugu et al 
18.06.2020 COVID-19 Across Africa: 
Epidemiologic Heterogeneity 
and Necessity of Contextually 
Relevant Transmission Models 
and Intervention Strategies  
Annals of Internal 
Medicine | Ideas 
and opinions 
Jean Olivier Twahirwa 
Rwema, Daouda Diouf, 
19.06.2020 Reordering gender systems: 
can COVID-19 lead to improved 
gender equality and health? 
Lancet | 
Comment 
Tania King, Belinda Hewitt 
Bradley Crammond, 
Georgina Sutherland, 
Humaira Maheen, Anne 
Kavanagh 
20.06.2020 Global governance for COVID-
19 vaccines 
Lancet | Editorial   
19.06.2020 Lockdown is not egalitarian: the 
costs fall on the global poor  
Lancet | 
Correspondence 
Alexander Broadbent, 
Damian Walker, Kalipso 
Chalkidou, Richard 
Sullivan, Amanda 
Glassman 
20.06.2020 COVID-19 resurgence in Iran Lancet | World 
Report 
Sharmila Devi 
18.06.2020 African countries set the tone in 
technological innovation to fight 
COVID-19 
Plos | Blog Azan Z. Virji, Jean Claude 
Mugunga 
19.06.2020 Covid-19 is testing the limits of 
the fragile healthcare system in 
Peru’s Amazon region 
BMJ | Opinion Kiran Mitha 
19.06.2020 Covid-19: Public health 
agencies review whether 
vitamin D supplements could 
reduce risk 
BMJ | News Ingrid Torjesen 
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16.06.2020 One Size Does Not Fit All: 
COVID-19 Responses Across 
African Settings 
SSHAP Social Science in 
Humanitarian Action 
Platform 
Guidelines, Statements & Tools 
Publication 
Date 
Title/URL Source   Summary 
22.06.2020 COVID-19 Safety 
Grades for 
Businesses—A 
Possible 
Mitigation Tool 
JAMA 
Health 
Forum 
 The trajectory of COVID-19 in the 
United States means no single public 
health solution, no matter how simple or 
complex, can eradicate this illness from 
our nation.  
 Therefore, we are left in a position that 
compels us to think creatively about 
developing pragmatic, rapidly 
deployable tools that will simultaneously 
allow for increased public autonomy 
and support disease mitigation during 
the next 18 to 24 months or until a 
vaccine becomes available. (these tools 
could also be used in LMICs) 
June 2020 COVID-19 
Considerations for 
Home and 
Community-Based 
Care 
SSHAP 
Briefing 
 Many guidelines from low- and middle-
income countries (LMICs) recognise the 
necessity to support home and 
community-based care for COVID-19 
(as deemed clinically appropriate, 
usually recommended only for ‘mild’ 
disease) for reasons such as to protect 
capacity in formal health care settings 
and to reduce the risk of infection 
spread in health facilities. 
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Dashboards & Trackers 
Cases & 
deaths: 
Global 
Cases & 
deaths: 
Regional 
Cases & 
deaths: 
Country 
Living 
evidence & 
policy maps 
Current 
research 
including trials 
  Diagnostics  Treatments   Vaccines 
WHO sitreps WHO 
Africa 
Ghana COVID-
NMA 
WHO   FIND 
SARS-CoV-
2 Test 
Tracker 
  Global 
COVID-19 
Clinical Trial 
Tracker 
  CEPI 
WHO 
dashboard 
African 
Arguments 
Indonesia EPPI 
Centre 
WHO 
International 
Clinical Trials 
Registry 
Platform 
(ICTRP) 
 FIND 
SARS-CoV-
2 
Diagnostics: 
performance 
data 
  US NIH 
registered 
clinical trials 
Vaccine 
Centre 
LSHTM 
Johns 
Hopkins 
University 
European 
CDC 
Nigeria 
CDC 
Norwegian 
Institute of 
Public 
Health 
Cytel  Serology-
based tests 
for COVID-
19 
  Solidarity 
trial 
 COVID-
19 Oxford 
Vaccine 
Trial 
WEF 
  Sierra 
Leone 
 Oxford C19 
Government 
Response 
Tracker 
(OxCGRT) 
US NIH  Our World 
in Data: C19 
Testing 
  COVID-19 
Therapeutics 
Accelerator 
  
Our World in 
Data 
  Singapore  Our World 
in Data: 
C19 Policy 
responses 
COVID-
evidence 
      
Global 5050 
  UK  IFPRI 
COVID-19 
Policy 
Response 
Portal 
Cochrane       
CEBM, 
University of 
Oxford 
  US  COVID-19 
Primer 
Clinicaltrials.gov       
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Humanitarian 
Data 
Exchange 
     NIH 
LitCovid 
 UKCDR       
Information 
is Beautiful 
     WHO 
COVID-19 
Database 
        
LSHTM               
HealthMap 
(cases) 
              
The 
Commons 
Project 
              
C19 Resource Hubs 
Global  Regional & 
Country 
Academic 
journals & 
Publishers 
Institutes/Centres
/Funders/Other 
Health 
Topics 
  Social 
Sciences 
WHO COVID-
19 pandemic  
Africa CDC Annals of 
Internal 
Medicine 
LSTM Stop TB 
Partnership 
  SSHAP 
WHO risk 
communication 
African 
Union 
BMJ LSHTM 
 
  IDA 
WHO Q&A Nigeria 
CDC 
Bulletin of 
the WHO 
ICL MRC Centre 
for Global 
Infectious 
Disease Analysis 
Global 
Menstrual 
Collective  
  Disability and 
inclusion 
WHO Global 
research 
GeoPoll: 
SSA 
Cambridge 
University 
Press 
ODI SLH: 
Handwashin
g in low 
resource 
settings 
  Coregroup 
IDDC 
24 
COVID-19 
Solidarity 
Response Fund 
Global 
Health 
Network 
Africa 
Cell Press Johns Hopkins 
University 
RBM 
Partnership 
  Ethics, health 
systems & 
COVID-19 
UN African 
Academy of 
Sciences 
Cochrane  Center for Global 
Development 
    Social 
Development 
Direct C19 
blog series 
UN Women Africa 
Evidence 
Network 
Elsevier CMMID 
Repository 
    
UNOCHA OCHA 
Southern 
and Eastern 
Africa 
COVID-19 
Digest 
JAMA 
Network 
Norwegian 
Institute of Public 
Health 
    
UNHCR  South 
African 
Government 
The 
Lancet 
Oxford Centre for 
Evidence-based 
Medicine 
    
UNICEF   medRxiv 
and 
bioRxiv 
(Preprints) 
 HEART     
UNESCO   NEJM  UKRI     
UN WFP   Oxford 
University 
Press 
 Evidence Aid     
GOARN   PLoS  NIH     
EPI-WIN   SAGE 
journals 
IFPRI Resources 
and Analyses of 
C19 Impact 
    
25 
World Bank   Science  Prevent 
Epidemics  
    
Our World in 
Data 
  Springer 
Nature 
      
COVID-19 
Narratives by 
David Nabarro 
  SSRN 
(Preprints)  
      
Reliefweb   Wiley       
Humanitarian 
OpenStreetMap 
Team 
          
Global 
Partnership for 
Sustainable 
Development 
Data 
  
 
      
WorldPop           
Flowminder           
COVID-END           
Premise 
COVID-19 
Global Impact 
Study 
    
  
GISAID           
  
26 
Online learning & events 
Date Title/URL Online 
learning/event 
Duration Lead 
30.06.2020 
1000 BST 
Clinical update: 
dexamethasone and 
hydroxychloroquine for 
treatment of severe 
COVID-19  
Webinar   African Academy of 
Sciences 
26.06.2020 
0900 to 
1030 EDT 
Monitoring and 
mitigating the collateral 
effects of COVID-19 
Online event 1h 30 CGD 
13 July 
3:00 PM – 
6:00 PM 
BST 
2020 UCL-Lancet 
Lecture: Global Health 
Preparedness by Dr 
Muhammad Pate, 
Global Director for 
Health, Nutrition and 
Population at the World 
Bank Group 
Online 
Lecture  
2 hour 
lecture, 1 
hour panel 
discussion 
UCL, The Lancet 
June 2020 OpenWHO, the free, 
open-access learning 
platform for health 
emergencies, now 
offers 10 online 
courses related to 
COVID19. 
Online 
courses 
Varies WHO 
24-
25.06.2020 
Africa’s leadership role 
in COVID-19 vaccine 
development and 
access 
Zoom webinar   African Union & Africa 
CDC 
Available 
now 
Standard precautions: 
Environmental cleaning 
and disinfection 
Online course 1 hour WHO 
27 
Available 
now 
COVID-19: Effective 
Nursing in Times of 
Crisis 
Online course 2 weeks – 2 
hours per 
week 
Johns Hopkins School 
of Nursing 
Available 
now 
WHO Academy and 
WHO Info mobile 
applications 
Mobile app   WHO 
Available 
now 
COVID-19: Pandemics, 
Modelling and Policy 
Online 
learning 
2 weeks | 2 
hours 
weekly 
study 
FutureLearn 
UNESCO UNITWIN 
Complex Systems 
Digital Campus/Open 
University 
12.05.2020 COVID-19 and 
maintaining quality 
essential health 
services  
Webinar 1 hour WHO & ISQua – Dr 
Shams Syed, Dr 
Peter Lachman, Dr 
Teri Rynolds & Dr Ed 
Kelley 
11.5.2020 COVID-19 Contact 
Tracing course 
Online 
learning 
5 hours Johns Hopkins 
Bloomberg School of 
Health 
7-28 May 
2020 
Virtual Evidence Weeks 5 sessions 1h 30 International Initiative 
for Impact Evaluation 
(3ie) 
Tuesdays 
at 1700 
CEST 
(Geneva 
time) & 
Thursdays 
0830 CEST 
(Geneva 
time) 
COVID-19 Open online 
brief with Dr David 
Nabarro 
Event 1h 4SD 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 
Event 1h 20 Gresham College 
28 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods for 
detection, prevention, 
response and control 
Online 
learning 
3 hours WHO 
Available 
now 
Responding to COVID-
19: Real-time training 
for the coronavirus 
disease outbreak 
Online 
learning 
Multiple 
self-paced 
course 
WHO 
25 May 
2020 
COVID-19: Tackling the 
Novel Coronavirus 
Online 
learning 
3 weeks | 4 
hours 
weekly 
study 
FutureLearn 
LSHTM/UK PHRST 
Available 
online now 
without 
mentors. 
Updated 
version will 
commence 
early June 
2020 
COVID-19 Diagnostics 
and Testing 
Online 
learning 
3 weeks | 3 
hours 
weekly 
study 
FutureLearn 
FIND/LSHTM/ASLM 
6 April 2020 COVID-19 Critical 
Care: Understanding 
and Application 
Online 
learning 
5 weeks | 1 
hour weekly 
study 
FutureLearn 
University of 
Edinburgh & Royal 
College of Physicians 
of Edinburgh  
Available 
now 
COVID-19 supporting 
online courses 
Online 
learning 
Multiple 
self-paced 
course 
BMJ Learning 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa” OR “South Asia” OR “Developing” OR “low-income” OR “low 
income” OR “lower-middle income” OR “low and middle income” OR “LMIC” OR “LIC” OR “global south”) OR 
(“poverty”) OR (“equity” OR “equities”), restricted to articles published in the previous 2 to 3 days, in English. This 
is complemented by a search of the homepage of the following high-impact global health journals: The Lancet 
journals, New England Journal of Medicine, Nature, JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ 
Global Health, the PLoS journals and a Twitter search of their Twitter pages. A search also of preprints from bioRxiv 
and medRxiv. Please note that papers that have not been peer-reviewed are highlighted in red. All primary 
research papers that relate to the primary and secondary impacts of the COVID-19 response in LMICs, and disease 
control and health system responses are included. Articles related to tackling the secondary impacts on other 
sectors are not included. Additional commentaries, opinions, and commissioned pieces are selected based on 
relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
About this report 
This is a weekly summary of the daily COVID-19 health evidence summary (HES) which are based on 3 hours of 
desk-based research each day. The summary is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to decision 
makers which, if relevant to them, they should go to before making decisions. The HES are not intended to replace 
medical or professional advice and the researcher or the K4D consortium cannot be held responsible for any 
decisions made about COVID-19 on the basis of the HES alone. K4D services are provided by a consortium of 
leading organisations working in international development, led by the Institute of Development Studies (IDS), with 
Education Development Trust, Itad, University of Leeds Nuffield Centre for International Health and Development, 
Liverpool School of Tropical Medicine (LSTM), University of Birmingham International Development Department 
(IDD) and the University of Manchester Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for International 
Development (DFID) and its partners in support of pro-poor programmes. It is licensed for 
non-commercial purposes only. K4D cannot be held responsible for errors, omissions or any 
consequences arising from the use of information contained in this health evidence summary. 
Any views and opinions expressed do not necessarily reflect those of DFID, K4D or any other 
contributing organisation.   
© DFID - Crown copyright 2020. 
